Quantum Technology in Health and Life Sciences
Drug makers and hospitals already run chemistry on quantum hardware. In 2026, Cleveland Clinic, RIKEN and IBM modelled a 12,635-atom protein–drug complex using an IBM quantum processor alongside the Fugaku supercomputer. In 2025, AstraZeneca, IonQ, AWS and NVIDIA ran a step of a reaction widely used in drug synthesis. IBM says its protein work does not yet beat the best classical methods, and none of these results claims to.
The clearest computing advantage is in strongly correlated chemistry, such as the cytochrome P450 enzymes that handle most drug metabolism. On published estimates, simulating a P450 active site needs roughly 1,000 to 4,900 logical qubits, and we expect the first partial simulations around 2031–2033. Quantum sensing and related spin technologies are closer to patients: hyperpolarized xenon MRI of the lungs has FDA approval, and wearable brain scanners are in clinical studies. In this course, we cover what each technology can do for health and life sciences, how to judge the claims, and what to prepare now.
Course Outline
Module 1. Judging Quantum Claims (45 minutes)
Quantum computing, sensing and networking mature at different speeds, and each needs its own tests. We separate results demonstrated on hardware from company announcements and from resource estimates. We also separate the physical qubits in current machines from the logical, error-corrected qubits required for useful computation. You learn to ask which classical method a result was compared with, and which roadmap dates are commitments and which are targets. We test each question on a recent pharma result, AstraZeneca’s 2025 reaction study, whose 20-fold speedup compares against earlier quantum runs.
Module 2. Quantum Computing for Drug Discovery (75 minutes)
We work through the chemistry problems with published resource estimates: drug-metabolizing P450 enzymes, photosensitizers for photodynamic cancer therapy, and protein–ligand binding. We explain the algorithms involved, from phase estimation on future error-corrected machines to the hybrid methods running on hardware today. We cover what quantum machine learning has and has not shown on biological data, and why protein folding and genomics claims need care. You learn to read a resource estimate for a target molecule and to ask for the classical baseline.
Module 3. Quantum Sensing and Health Data (45 minutes)
We cover optically pumped magnetometers for brain imaging, now in clinical studies for epilepsy, and nanodiamond sensors in rapid diagnostic tests. We explain what regulatory approval means for these devices, with hyperpolarized xenon lung MRI as the approved example. We also cover the protection of health, imaging and genomic data that must stay confidential for many years. We explain why agencies such as NSA recommend post-quantum cryptography over quantum key distribution.
Module 4. What Pharma and Health Systems Are Doing (30 minutes)
We review named programs and what each result shows. They include Cleveland Clinic with IBM and RIKEN, AstraZeneca with IonQ, AWS and NVIDIA, Moderna and IBM, and Boehringer Ingelheim’s estimates with Google and PsiQuantum. We cover the Novo Nordisk Foundation’s quantum programs, including the 50-logical-qubit Magne machine on order in Denmark, and the clinical studies of wearable brain scanners. For each, you learn whether it reports a hardware result, an announcement or an estimate.
Module 5. Preparing Now (45 minutes)
We show you how to name the three to five molecular systems in your pipeline where strongly correlated chemistry blocks a decision. You learn to score each problem on value, classical difficulty and quantum resources, and to build hybrid workflows your computational chemists can run today. We cover partnerships with hardware providers, pre-competitive programs, and early talks with regulators about validating quantum-derived results. In a working exercise, you draft a one-page quantum brief for your R&D leadership.
Prerequisites
None.
Who this course is for
R&D and innovation leads, computational chemists, data scientists, executives and program managers at pharmaceutical, biotech and medical-device companies. Also useful for hospital and research-institute leaders weighing quantum partnerships, and for investors and consultants in life sciences.
What you’ll be able to do afterward
- Explain what quantum computing, sensing and networking can and cannot do for health and life sciences today
- Read a resource estimate for a target molecule and judge when it might become feasible
- Tell a hardware result from an announcement or an estimate, and a gain over earlier quantum methods from a gain over classical ones
- Identify the molecular problems in your pipeline that are candidates for quantum simulation
- Assess quantum sensing devices by their clinical evidence and regulatory status
- Plan skills, partnerships and data protection for the next five years
What you leave with
When you finish, we email you the course handbook, a PDF of every slide with notes that explain it in full. It includes a table of the use cases covered, each labelled as demonstrated, announced or estimated, with its sources. We also include a PDF copy of Quantum Systems Integration. The handbook is yours to keep.
Enrollment includes 180 days of access to the online on-demand course. Where that course is not yet published, the 180 days start on the day it is.
Where this course fits
You can take this course on its own. No technical background is assumed. For the security side, take Quantum-Safe Healthcare or, for drug makers, the Quantum-Safe Pharma Intensive. Computational teams can continue with Quantum Computing Fundamentals. Device teams can continue with Quantum Sensing Fundamentals. Quantum Technology for Chemicals and Materials covers the simulation methods in more depth.
Why we teach this
The material is based on Quantum Systems Integration, the reference text on quantum computing, networking, and sensing written by the course author. It also draws on faculty who work with quantum engineering and integration teams, and on the published resource estimates for each use case. We label every result in the course as demonstrated on hardware, announced by a company or estimated, so you can see how far each one has progressed.
Certificate of Completion
Upon completion, you receive a Quantum Academy certificate of completion. It confirms that you completed the course and is separate from Quantum Academy’s professional certifications.
About this program
Quantum Academy credentials are private professional credentials issued by Quantum Academy, a trade name of Post-Quantum Institute. They are not government-issued licenses, accredited degrees, or academic credit, and earning one does not guarantee employment, promotion, regulatory approval, or any other specific outcome.
Quantum Academy programs are educational and informational only, and are not legal, compliance, or engineering advice.
